Vicarious Surgical Inc.
Vicarious Surgical Inc. (RBOT) Stock Overview
Explore Vicarious Surgical Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
47.5M
P/E Ratio
-0.77
EPS (TTM)
$-10.44
ROE
-1.17%
RBOT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Vicarious Surgical Inc. (RBOT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.28.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.77 and a market capitalization of 47.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Analyst Recommendations
Price Targets
Company Profile
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Adam David Sachs
123
78 Fourth Avenue, Waltham, MA
2020